Clinical Trial Update: Long-Term Safety Performance of Fexofenadine in Asthma [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the long-term safety of fexofenadine in patients with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fexofenadine (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED